ctrl K

Watchlist Price Alert

Kalaris Therapeutics Inc (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

2.58

0.02 (0.78%)

At close: Jun 27, 2025, 3:59 PM

2.52

-2.51%

After-hours: Jun 27, 2025, 07:01 PM EDT

Kalaris Therapeutics Inc Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2023
Period Ending	Dec 31, 2023
Revenue	n/a
Cost of Revenue	n/a
Gross Profit	n/a
Operating Income	-3.46M
Interest Income	n/a
Pretax Income	-3.47M
Net Income	-3.47M
Selling & General & Admin	498K
Research & Development	2.97M
Other Expenses	n/a
Operating Expenses	3.46M
Interest Expense	39K
Selling & Marketing Expenses	n/a
Cost & Expenses	3.46M
Income Tax Expense	n/a
Shares Outstanding (Basic)	n/a
Shares Outstanding (Diluted)	n/a
EPS (Basic)	n/a
EPS (Diluted)	n/a
EBITDA	-3.43M
EBIT	-3.43M
Depreciation & Amortization	n/a